World Diagnostics nears market in India and Nepal:
This article was originally published in Clinica
World Diagnostics has received a licence to sell its One Step point-of-care malaria test in India and at the same time, has concluded initial sales of its HIV and hepatitis Smart Check rapid tests to the government of Nepal. In the Indian development, the Miami Lakes, Florida-based company says shipments by its distributor, Mumbai-based Unicorn Medical, are expected to begin by October and could reach up to $500,000 for the year ended March 2003. In Nepal, the tests will form part of the Nepalese government's surveillance programme to identify and measure the presence of HIV/AIDS and hepatitis in rural areas. The Red Cross Nepal will also evaluate the tests for use in its blood bank screening programme.
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.